{{Chembox
| ImageFile = zolertine.svg
| ImageSize = 200px
| ImageAlt = 
| IUPACName = 1-Phenyl-4-[2-(tetrazol-5-yl)ethyl]piperazine
| OtherNames = 
|Section1={{Chembox Identifiers
| CASNo = 4004-94-8
| PubChem = 23669
| ChemSpiderID = 22131
| InChI = 1/C13H18N6/c1-2-4-12(5-3-1)19-10-8-18(9-11-19)7-6-13-14-16-17-15-13/h1-5H,6-11H2,(H,14,15,16,17)
| InChIKey = XTTHMUYLNLEJRS-UHFFFAOYAE
| StdInChI = 1S/C13H18N6/c1-2-4-12(5-3-1)19-10-8-18(9-11-19)7-6-13-14-16-17-15-13/h1-5H,6-11H2,(H,14,15,16,17)
| StdInChIKey = XTTHMUYLNLEJRS-UHFFFAOYSA-N
| SMILES = C1CN(CCN1CCC2=NNN=N2)C3=CC=CC=C3}}
|Section2={{Chembox Properties
| C=13 | H=18 | N=6
| Appearance = 
| Density = 
| MeltingPt = 
| BoilingPt = 
| Solubility = }}
|Section3={{Chembox Hazards
| MainHazards = 
| FlashPt = 
| AutoignitionPt = }}
}}

'''Zolertine''' is an [[alpha-adrenoceptor antagonist]].<ref>{{cite journal|pmid=11193002|year=2000|last1=Ibarra|first1=M|last2=Hong|first2=E|last3=Villalobos-Molina|first3=R|title=The alpha-adrenoceptor antagonist, zolertine, inhibits alpha1D- and alpha1A-adrenoceptor-mediated vasoconstriction in vitro|volume=20|issue=3|pages=139â€“45|journal=Journal of autonomic pharmacology}}</ref>

==References==
{{Reflist|2}}


{{Adrenergics}}

[[Category:Alpha blockers]]
[[Category:Tetrazoles]]
[[Category:Piperazines]]


{{pharma-stub}}